Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • About
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Treatment for Bipolar I Disorder”

95 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 95 results

Large-scale testing (Phase 3)Study completedNCT00868959
What this trial is testing

Lurasidone - A 24-week Extension Study of Patients With Bipolar I Depression

Who this might be right for
Bipolar Depression
Sumitomo Pharma America, Inc. 817
Large-scale testing (Phase 3)Ended earlyNCT01467713
What this trial is testing

Efficacy and Safety of Ramelteon Sublingual as Adjunctive Therapy for Maintenance Treatment of Bipolar I Disorder

Who this might be right for
Bipolar Disorder
Takeda 642
Post-approval studies (Phase 4)Study completedNCT00181727
What this trial is testing

Study of Depakote ER for the Treatment of Mania in Children Ages 6-12 With Bipolar Disorder

Who this might be right for
Bipolar DisorderMania
Massachusetts General Hospital 14
Large-scale testing (Phase 3)Study completedNCT00266630
What this trial is testing

Efficacy and Safety of Olanzapine in the Extended Treatment for Manic or Mixed Episode of Bipolar I Disorder

Who this might be right for
Manic or Mixed Episode Associated With Bipolar I Disorder
Eli Lilly and Company 139
Not applicableStudy completedNCT01655030
What this trial is testing

Creatine Monohydrate as Adjuvant Therapy for Bipolar Depression

Who this might be right for
Bipolar I DisorderCurrent Episode Depressed
University of Sao Paulo 44
Large-scale testing (Phase 3)Ended earlyNCT01467700
What this trial is testing

Efficacy and Safety of Ramelteon Sublingual in Adult Patients With Acute Depressive Episodes Associated With Bipolar I Disorder

Who this might be right for
Acute Depressive Episode
Takeda 490
Post-approval studies (Phase 4)Study completedNCT00844857
What this trial is testing

Assessing Treatment of Patients Ages 10-17 With Bipolar Depression

Who this might be right for
Bipolar Depression
Eli Lilly and Company 291
Large-scale testing (Phase 3)WithdrawnNCT01685151
What this trial is testing

A Safety and Efficacy Study of Ramelteon Tablets for Sublingual Administration (TAK-375SL) in the Maintenance Treatment of Bipolar 1 Disorder

Who this might be right for
Bipolar Disorder
Takeda
Post-approval studies (Phase 4)WithdrawnNCT01495156
What this trial is testing

Study of the Efficacy of Adjunctive Lithium Treatment for the Treatment of Psychotic Mania

Who this might be right for
Bipolar I Disorder
Northwell Health
Large-scale testing (Phase 3)Study completedNCT04819776
What this trial is testing

Evaluation of Efficacy and Safety of Iloperidone in the Acute Treatment of Manic or Mixed Episodes Associated With Bipolar I Disorder

Who this might be right for
Bipolar I Disorder
Vanda Pharmaceuticals 417
Large-scale testing (Phase 3)Study completedNCT00114686
What this trial is testing

Efficacy and Safety of Quetiapine Fumarate (SEROQUEL®) in the Treatment of Alcohol Dependency in Patients With Bipolar Disorder

Who this might be right for
Bipolar I DisorderAlcohol Dependence
AstraZeneca 350
Large-scale testing (Phase 3)Study completedNCT00618748
What this trial is testing

Safety and Efficacy of Olanzapine in the Long-term Treatment for Bipolar I Disorder, Depressed

Who this might be right for
Bipolar I Disorder
Eli Lilly and Company 101
Large-scale testing (Phase 3)Study completedNCT00037674
What this trial is testing

A Study on the Safety and Efficacy of Topiramate in the Treatment of Patients With Bipolar I Disorder

Who this might be right for
Bipolar Disorder
Johnson & Johnson Pharmaceutical Research & Development, L.L.C. 434
Large-scale testing (Phase 3)Study completedNCT03249376
What this trial is testing

Lumateperone Monotherapy for the Treatment of Bipolar Depression Conducted Globally

Who this might be right for
Bipolar Depression
Intra-Cellular Therapies, Inc. 381
Large-scale testing (Phase 3)Study completedNCT01244815
What this trial is testing

Efficacy and Safety of Asenapine Treatment for Pediatric Bipolar Disorder (P06107 Has an Extension [P05898; NCT01349907])(P06107)

Who this might be right for
Bipolar Disorder, Pediatric
Organon and Co 404
Testing effectiveness (Phase 2)Ended earlyNCT02839798
What this trial is testing

NeoSync TMS Treatment for Bipolar I Depression

Who this might be right for
Major Depressive EpisodeBipolar DepressionBipolar Disorder+1 more
Butler Hospital 6
Large-scale testing (Phase 3)Study completedNCT00391222
What this trial is testing

Evaluate the Efficacy and Safety of Risperidone for the Prevention of Mood Episodes in the Treatment of Patients With Bipolar I Disorder

Who this might be right for
Bipolar Disorder
Janssen Pharmaceutica N.V., Belgium 585
Large-scale testing (Phase 3)Study completedNCT01977300
What this trial is testing

Atypical Antipsychotics for Continuation and Maintenance Treatment After an Acute Manic Episode

Who this might be right for
Bipolar I Disorder
University of British Columbia 159
Large-scale testing (Phase 3)Looking for participantsNCT06372964
What this trial is testing

Multicenter Study of Lumateperone for the Treatment of Bipolar Depression in Pediatric Patients

Who this might be right for
Bipolar Depression
Intra-Cellular Therapies, Inc. 384
Large-scale testing (Phase 3)Looking for participantsNCT06951698
What this trial is testing

Evaluate the Efficacy and Safety of KarXT for the Treatment of Manic Episodes in Bipolar-I Disorder

Who this might be right for
Bipolar-I Disorder With Mania or Mania With Mixed Features
Bristol-Myers Squibb 274
Load More Results